Prenatal DNA Sequencing Market Forecast 2024-2033

Overview and Scope
Prenatal DNA sequencing refers to a method of sequencing the DNA of an unborn baby by using the blood sample from the mother that helps to reveal the full genetic code of the unborn baby. It is used to detect fetal disorders or diseases.

Sizing and Forecast
The prenatal dna sequencing market size has grown rapidly in recent years. It will grow from $2.23 billion in 2023 to $2.56 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to changing patient preferences, medical advancements and research, non-invasive testing adoption, rising maternal age, improved accuracy and reliability..

The prenatal dna sequencing market size is expected to see rapid growth in the next few years. It will grow to $4.56 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to consumer demand for early detection, rising maternal age and pregnancy risks, public health initiatives, regulatory support and guidelines, advancements in data analysis.. Major trends in the forecast period include research and development efforts, ethical and regulatory considerations, improved data interpretation tools, precision medicine integration, prenatal genetic counseling..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

Segmentation & Regional Insights
The prenatal dna sequencing market covered in this report is segmented –

1) By Type: Genetic Diseases, Nonhereditary Diseases
2) By Application: Hemophilia, Down Syndrome, Cystic Fibrosis, Autism, DiGeorgre Syndrome, AIDS (Acquired Immunodeficiency Syndrome), Cancer, Other Applications
3) By End User: Academic Research, Clinical Research, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

North America was the largest region in the prenatal DNA sequencing market in 2023. The regions covered in the prenatal dna sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=9015&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of cancer is expected to propel the growth of the prenatal DNA sequencing market going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. Prenatal DNA sequencing in cancer is used to detect fetal aneuploidy in maternal plasma and to identify cancer in the fetus. The sequencing reveals the inherited or germline DNA changes that raise a person’s chance of developing cancer. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth of 3.16%. , Therefore, the prevalence of cancer is driving the prenatal DNA sequencing market.

Key Industry Players

Major companies operating in the prenatal DNA sequencing market report are Agilent Technologies Inc., BGI Group, F. Hoffmann-La Roche Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Genomic Health Inc., Myriad Genetics Inc., Invitae Corporation, PerkinElmer Inc., Macrogen Inc., Pacific Biosciences of California Inc., Genewiz LLC, 10x Genomics Inc., Oxford Nanopore Technologies Limited, Thermo Fisher Scientific Inc., Berry Genomics Co. Ltd., Centrillion Technology Holdings Corp., Cynvenio Biosystems Inc., Eurofins LifeCodexx AG, Fluidigm Corp., GATC Biotech AG, GeneDx Inc., Genoma SA, Good Start Genetics Inc., Helix OpCo LLC, Igenomix S.L., Integrated DNA Technologies Inc., KellBenx Inc., LifeCodexx AG .

The prenatal dna sequencing market report table of contents includes:

1. Executive Summary

2. Prenatal DNA Sequencing Market Characteristics

3. Prenatal DNA Sequencing Market Trends And Strategies

4. Prenatal DNA Sequencing Market – Macro Economic Scenario

5. Global Prenatal DNA Sequencing Market Size and Growth

.
.
.

31. Global Prenatal DNA Sequencing Market Competitive Benchmarking

32. Global Prenatal DNA Sequencing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Prenatal DNA Sequencing Market

34. Prenatal DNA Sequencing Market Future Outlook and Potential Analysis

35. Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model